NEW DELHI, July 31, 2024 — Guru Gobind Singh Indraprastha University (GGSIPU), widely known as IP University, has announced the launch of its innovative DPharma program for the 2024-25 academic session. This two-year course, hosted at the Centre of Excellence in Pharmaceutical Sciences (CEPS) on the Dwarka campus, marks a major advancement in pharmaceutical education and research.
IP University DPharma Program Highlights
Program Details:
- Duration: Two years
- Intake: 60 seats
- Location: CEPS, Dwarka campus
Dr. Mahesh Verma, Vice-Chancellor of IP University, emphasized the program’s significance: “Our new DPharma program represents a significant leap forward in pharmaceutical education. We’ve designed a curriculum that meets current industry standards and anticipates future trends in drug discovery, development, and delivery.”
Cutting-Edge Curriculum and Industry Collaboration
The curriculum, developed with input from leading pharmaceutical companies, integrates advanced theoretical knowledge with hands-on practical experience. It covers areas such as:
- Advanced Drug Formulation Techniques
- Pharmaceutical Biotechnology
- Regulatory Affairs and Quality Assurance
- Pharmacovigilance and Clinical Research
- Artificial Intelligence in Drug Discovery
Dr. Rajesh Sharma, Dean of CEPS at IP University, stated: “Our partnerships with top pharmaceutical firms ensure our students receive real-world exposure, including internships, guest lectures, and collaborative research projects.”
Streamlined Admission Process
For the 2024-25 session, IP University has streamlined the admission process by eliminating the IPU CET test, basing admissions on class 12 marks instead. This change aims to attract a diverse pool of talented students nationwide.
Dr. Anita Singh, Head of Admissions at IP University, explained:
“We believe this new process will help us attract students passionate about pharmaceutical sciences. Eligible candidates must have completed class 12 with a minimum of 50% marks in the science stream.”
How to Apply for the IP University DPharma Program
Interested students can apply for the DPharma program by following these steps:
- Visit the official website: ipu.admissions.nic.in
- Download the application form
- Complete the form with accurate information, including class 12 marks
- Prepare a draft of Rs 2,500 in favor of the Registrar
- Submit the form and draft at the University Facilitation Centre by August 14, 2024, 3 PM
CEPS Facilities IP University DPharma
The DPharma program will be conducted at CEPS, which boasts state-of-the-art facilities, including:
- Advanced Drug Testing Laboratories
- Pharmaceutical Biotechnology Research Center
- Simulated GMP Facility
- Virtual Reality-enabled Pharmacology Lab
- AI-powered Drug Design Studio
Dr. Priya Gupta, Director of Research at CEPS, highlighted: “Our facilities at CEPS are on par with the best in the world, equipping students with the tools and technologies used in leading pharmaceutical companies.”
Pharmaceutical Industry
The DPharma program is expected to have a significant impact on the pharmaceutical industry by producing highly trained graduates ready to meet industry demands.
Dr. Rakesh Patel, CEO of a leading pharmaceutical company and member of IP University’s advisory board, commented:
“This program addresses a crucial need in our industry. Graduates from IP University’s DPharma program will be well-equipped to drive innovation and excellence in pharmaceutical research and development.”
The launch of the DPharma program reaffirms IP University’s position as a leader in pharmaceutical education.
With its innovative curriculum, cutting-edge facilities, and strong industry connections, the DPharma program is set to attract aspiring pharmacists from across the country for the 2024-25 academic session.
